SOLBAR NINGBO PROTEIN TECH CO L (603231.SS)
CNY 17.06
(-1.56%)
CNY 17.06
(-1.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 144.3 Million | 186.38 Million | 161.94 Million | 199.31 Million | 44.43 Million |
| Net Income | 150.34 Million | 168.02 Million | 123.93 Million | 97.74 Million | 65.99 Million |
| Depreciation & Amortization | 60.23 Million | 53.57 Million | 45.41 Million | 43.67 Million | 43 Million |
| Deferred income taxes | 49.02 Thousand | - | -1.33 Million | -1.26 Million | -51.7 Thousand |
| Stock-based compensation | - | - | 1.57 Million | 9.01 Million | 8.66 Million |
| Change in working capital | -75.2 Million | -41.67 Million | -23.58 Million | 54.81 Million | -73.66 Million |
| Other non-cash items | 204.58 Million | 5.68 Million | 134.35 Million | 49.32 Million | 177.59 Million |
| Investing Cash Flow | -95.84 Million | -143.69 Million | -111.87 Million | -43.03 Million | -126.04 Million |
| Investments in PPE | -99.66 Million | -144.11 Million | -160.52 Million | -72.53 Million | -38.41 Million |
| Acquisitions | 3 Million | - | 802.68 Thousand | 157.39 Thousand | 151.1 Thousand |
| Investment purchases | -212.7 Million | - | -9 Million | -437.5 Thousand | - |
| Sales/Maturities of investments | 395.95 Thousand | 160.47 Thousand | 357.58 Thousand | 1.5 Million | - |
| Other Investing Activities | 213.52 Million | -806.38 Thousand | 56.49 Million | 29.77 Million | -87.77 Million |
| Financing Cash Flow | 936.67 Million | -82.01 Million | 8.05 Million | -110.14 Million | 57.65 Million |
| Debt repayment | -1.22 Million | -18 Million | -83 Million | -19 Million | -9 Million |
| Dividends payments | -43.07 Million | -63.08 Million | -74.09 Million | -29.78 Million | -36.74 Million |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | 980.97 Million | -931.06 Thousand | -74.94 Million | -91.14 Million | 66.65 Million |
| Accounts receivables | -28.29 Million | -19.57 Million | -35.4 Million | 26.66 Million | -44.92 Million |
| Accounts payables | -74.72 Million | - | 66.76 Million | -3.77 Million | -29.79 Million |
| Inventory | 27.78 Million | -55.78 Million | -57.36 Million | 19.49 Million | -7.71 Million |
| Other working capital | 27.09 Thousand | -4.39 Million | 2.42 Million | 12.44 Million | 8.76 Million |
| Cash at beginning of period | 122.98 Million | 122.97 Million | 70.26 Million | 23.05 Million | 47.01 Million |
| Cash at end of period | 1.07 Billion | 88.03 Million | 122.98 Million | 70.26 Million | 23.05 Million |
| Capital Expenditure | -99.66 Million | -144.11 Million | -160.52 Million | -72.53 Million | -38.41 Million |
| Effect of forex changes on cash | -27.09 Thousand | 4.39 Million | -852.04 Thousand | -3.42 Million | -100.33 Thousand |
| Net cash flow / Change in cash | 950.16 Million | -34.93 Million | 52.71 Million | 47.21 Million | -23.96 Million |
| Free Cash Flow | 44.63 Million | 42.27 Million | 1.42 Million | 126.78 Million | 6.01 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 20.88 Million | 33.53 Million | 37.26 Million | 31.25 Million | 150.34 Million | - |
| Depreciation & Amortization | - | 16.97 Million | 16.97 Million | 15.11 Million | 60.23 Million | - |
| Deferred income taxes | - | - | - | - | 49.02 Thousand | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | -479.39 Thousand | -75.2 Million | - |
| Other non-cash items | 77.18 Million | -7.65 Million | -18.71 Million | -58.16 Million | 204.58 Million | - |
| Investing Cash Flow | -76.48 Million | -9.63 Million | -675.34 Million | 24.22 Million | -95.84 Million | -42.93 Million |
| Investments in PPE | -25.55 Million | -15.14 Million | -15.72 Million | -20.43 Million | -99.66 Million | -18.97 Million |
| Acquisitions | -420 Thousand | 532.2 Thousand | 136.2 Thousand | - | 3 Million | - |
| Investment purchases | 1.04 Billion | -1.04 Billion | - | - | -212.7 Million | - |
| Sales/Maturities of investments | 6.59 Million | 385.22 Million | - | 176.64 Thousand | 395.95 Thousand | 106.82 Thousand |
| Other Investing Activities | -57.51 Million | 703.81 Million | -659.76 Million | 43.05 Million | 213.52 Million | -25.04 Million |
| Financing Cash Flow | -1.05 Million | -180.15 Million | -67.93 Million | 984.62 Million | 936.67 Million | -21.04 Million |
| Debt repayment | - | -100 Thousand | -59.9 Million | - | -1.22 Million | -20 Million |
| Dividends payments | -791.78 Thousand | -95.38 Million | -297.8 Thousand | -485.33 Thousand | -43.07 Million | -625.58 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -260.48 Thousand | -178.98 Million | -8.03 Million | 985.11 Million | 980.97 Million | -421.25 Thousand |
| Accounts receivables | - | - | - | -28.29 Million | -28.29 Million | - |
| Accounts payables | - | - | - | - | -74.72 Million | - |
| Inventory | - | - | - | 27.78 Million | 27.78 Million | - |
| Other working capital | - | - | - | 27.09 Thousand | 27.09 Thousand | - |
| Cash at beginning of period | 171.58 Million | 350.78 Million | 1.07 Billion | 75.47 Million | 122.98 Million | 74.76 Million |
| Cash at end of period | 184 Million | 171.59 Million | 350.78 Million | 1.07 Billion | 1.07 Billion | 75.47 Million |
| Capital Expenditure | -25.55 Million | -15.14 Million | -15.72 Million | -20.43 Million | -99.66 Million | -18.97 Million |
| Effect of forex changes on cash | -1.52 Million | 1.68 Million | 2.37 Million | 1.08 Million | -27.09 Thousand | -482.26 Thousand |
| Net cash flow / Change in cash | 12.42 Million | -179.19 Million | -722.35 Million | 997.66 Million | 950.16 Million | 710.59 Thousand |
| Free Cash Flow | 72.51 Million | -6.24 Million | 2.83 Million | -32.7 Million | 44.63 Million | -18.97 Million |
AMXEF
HUI
MAPS
MJHI
DIKSAT
FNVTW